Viatris, Inc. (VTRS)
20.84
+0.17
(+0.82%)
USD |
NASDAQ |
Nov 13, 16:00
20.75
-0.09
(-0.43%)
After-Hours: 19:59
Viatris Enterprise Value : 35.38B for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 35.38B |
| November 11, 2026 | 35.82B |
| November 10, 2026 | 35.58B |
| November 09, 2026 | 35.17B |
| November 06, 2026 | 34.51B |
| November 05, 2026 | 33.43B |
| November 04, 2026 | 33.71B |
| November 03, 2026 | 33.37B |
| November 02, 2026 | 33.08B |
| October 30, 2026 | 33.50B |
| October 29, 2026 | 33.69B |
| October 28, 2026 | 33.20B |
| October 27, 2026 | 33.14B |
| October 26, 2026 | 32.65B |
| October 23, 2026 | 32.32B |
| October 22, 2026 | 32.87B |
| October 21, 2026 | 32.83B |
| October 20, 2026 | 33.06B |
| October 19, 2026 | 32.61B |
| October 16, 2026 | 33.07B |
| October 15, 2026 | 32.57B |
| October 14, 2026 | 31.67B |
| October 13, 2026 | 31.46B |
| October 12, 2026 | 31.79B |
| October 09, 2026 | 31.90B |
| Date | Value |
|---|---|
| October 08, 2026 | 31.67B |
| October 07, 2026 | 31.73B |
| October 06, 2026 | 31.79B |
| October 05, 2026 | 31.88B |
| October 02, 2026 | 31.86B |
| October 01, 2026 | 31.70B |
| September 30, 2026 | 31.99B |
| September 29, 2026 | 33.15B |
| September 28, 2026 | 33.32B |
| September 25, 2026 | 32.81B |
| September 24, 2026 | 32.34B |
| September 23, 2026 | 31.99B |
| September 22, 2026 | 32.06B |
| September 21, 2026 | 31.97B |
| September 18, 2026 | 31.80B |
| September 17, 2026 | 32.01B |
| September 16, 2026 | 31.88B |
| September 15, 2026 | 31.45B |
| September 14, 2026 | 31.46B |
| September 11, 2026 | 31.29B |
| September 10, 2026 | 31.14B |
| September 09, 2026 | 31.28B |
| September 08, 2026 | 31.41B |
| September 04, 2026 | 31.72B |
| September 03, 2026 | 31.79B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Pacira Biosciences, Inc. | 1.499B |
| Pfizer Inc. | 213.03B |
| Eli Lilly & Co. | 1.388T |
| Merck & Co., Inc. | 406.57B |
| Amphastar Pharmaceuticals, Inc. | 1.690B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -325.30M |
| Revenue (Quarterly) | 3.752B |
| Total Expenses (Quarterly) | 4.077B |
| EPS Diluted (Quarterly) | -0.2832 |
| Gross Profit Margin (Quarterly) | 41.68% |
| Profit Margin (Quarterly) | -8.67% |
| Earnings Yield | -2.54% |
| Operating Earnings Yield | 6.55% |
| Normalized Earnings Yield | 2.248 |